Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Axel Nelson
Observed name:
Nelson, Axel
Institutions:
Sahlgrenska University Hospital,
Region Västra Götaland,
University of Gothenburg
Observed institutions:
Sahlgrenska University Hospital,
Region Västra Götaland,
University of Gothenburg
ORCID:
0009-0005-8898-8301
Observed ORCID:
0009-0005-8898-8301
OpenAlex ID:
A5107952218
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
2023
·
Roger Olofsson Bagge
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
·
79
PDF
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM
2024
·
Roger Olofsson Bagge
, Axel Nelson
, et al.
·
Annals of Surgery
·
24
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma – A Swedish retrospective real-world study (NEO-MEL)
2025
·
Axel Nelson
, Ellen Krabbe
, et al.
·
European Journal of Cancer
·
18
PDF
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).
2022
·
Roger Olofsson Bagge
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
·
9
A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).
2023
·
Roger Olofsson Bagge
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
·
6
Time of day of neoadjuvant immune checkpoint inhibitor administration is associated with survival but not pathological response in resectable stage III–IV melanoma: A retrospective cohort study
2026
·
Axel Nelson
, Safa Alghaib
, et al.
·
European Journal of Cancer
·
2
Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial).
2023
·
Roger Olofsson Bagge
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma – Different Outcomes Between Patients With Lymph Node and In-transit Metastases
2026
·
Ellen Krabbe
, Anne Huibers
, et al.
·
Annals of Surgery
·
1
Nodal localisation with magnetic seed in patients with stage III melanoma receiving neoadjuvant immune checkpoint inhibitors, a feasibility study
2026
·
Ellen Krabbe
, Anne Huibers
, et al.
·
European Journal of Surgical Oncology
·
1
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial)
2026
·
Axel Nelson
, Rebecca Riise
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial).
2024
·
Axel Nelson
, Amir Shafazand
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Neoadjuvant immunotherapy for resectable stage III cutaneous melanoma—comparison between patients with lymph node and in-transit metastases
2026
·
Ellen Krabbe
, Anne Huibers
, et al.
·
British journal of surgery
PDF
Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohort
2026
·
Axel Nelson
, Ellen Krabbe
, et al.
·
JNCI Journal of the National Cancer Institute
Outcome of neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish nationwide population-based study (NEO-MEL).
2026
·
Axel Nelson
, Ellen Krabbe
, et al.
·
Journal of Clinical Oncology
Adjuvant versus no adjuvant therapy after major pathological response to neoadjuvant immunotherapy in resectable melanoma: A Swedish nationwide population-based study (NEO-MEL).
2026
·
Axel Nelson
, Ellen Krabbe
, et al.
·
Journal of Clinical Oncology
Selecting Representative Tumour Bed Slices May Allow Reduced Embedding Without Loss of Accuracy in Response Evaluation to Neoadjuvant Immunotherapy in Stage IIIB/C Cutaneous Melanoma
2026
·
Anders Bergström
, Axel Nelson
, et al.
·
Cancers
PDF
Abstract CT194: Local administration of tumor infiltrating lymphocytes by hepatic artery infusion in patients with uveal melanoma and liver metastases
2026
·
Axel Nelson
, Rebecca Riise
, et al.
·
Cancer Research
Neoadjuvant immunotherapy for patients with resectable melanoma
2025
·
Axel Nelson
, Ellen Krabbe
, et al.
·
British journal of surgery
Magnetic seed localization in patients with nodal stage III melanoma and neoadjuvant immunotherapy, a feasibility study
2025
·
Ellen Krabbe
, Andrew Wong
, et al.
·
British journal of surgery
The prognostic and predictive value of the immunological gene signatures interferon gamma and TIDE for patients with liver metastases from uveal melanoma treated with isolated hepatic perfusion.
2025
·
Måns Kadefors
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
PDF
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.
2025
·
Måns Kadefors
, Axel Nelson
, et al.
·
Journal of Clinical Oncology
PDF
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL).
2025
·
Axel Nelson
, Ellen Krabbe
, et al.
·
Journal of Clinical Oncology
72206 - Overall Survival after Isolated Hepatic Perfusion in Combination with Ipilimumab and Nivolumab in Patients with Uveal Melanoma (SCANDIUM II trial)
2024
·
Axel Nelson
, Amir Shafazand
, et al.
·
British journal of surgery
PDF
71691 - Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)
2024
·
Axel Nelson
, Amir Shafazand
, et al.
·
British journal of surgery
PDF
Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial).
2024
·
Axel Nelson
, Amir Shafazand
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
26
Citation count:
144
H-index:
5
I10-index:
3
Year
Topic
Type